Ücretsiz, salt okunur, anahtar gerekmez
Atlas API'si
Bu siteyi oluşturan veritabanının JSON formatı. Atıf ve geri bağlantı ile ticari olmayan kullanım için ücretsizdir. Lütfen yanıtları önbelleğe alın ve istek hızını makul düzeyde tutun.
Endpoints
| Endpoint | Returns |
|---|---|
| /api/v1/stats | Record counts by kind, plus the number of graph connections. |
| /api/v1/entities?kind=… | All records of one kind, with status, evidence level and structured data. Kinds: technology, disease, treatment, trial, company, scientist, gene, paper, institution, ethics, agriculture, learn, glossary, comparison, list. |
| /api/v1/entity/{kind}/{slug} | One record in full, including body text, facts, sources and every related record in the knowledge graph. |
| /api/v1/trials?phase=&status= | The trial database, filterable by phase and status. |
| /api/v1/news?limit=40 | Recent headlines with publisher and link. Article text stays with its publisher. |
| /api/search?term=… | Type-ahead search across every record kind. |
| /sitemap.xml | Every URL on the site, with last-modified dates. |
Currently serving
17Technologies
19Diseases
15Treatments
14Clinical Trials
17Companies
12Scientists
19Genes
11Research
8Institutions
8Ethics
9Agriculture
26Learn
94Glossary
8Comparisons
11Lists & Rankings
Reading the fields
evidence— one of: Approved treatment, Clinical research, Preclinical research, Laboratory research, Future possibility. This is the field that tells you how seriously to take a claim.status— regulatory or development stage (Approved, Phase III, Preclinical, Discontinued and so on), or trial recruitment status for trial records.updated— when the record was last edited. Compiled data lags its sources; treat this as the age of the claim.related— on single-entity responses, every connected record grouped by kind, with its relationship.
Terms
Attribution required: name The CRISPR Atlas and link to the page you took data from. Values are compiled from the public sources cited on each page and may be incomplete, delayed or revised — verify against the primary source before relying on them. The API carries no medical or investment advice and must not be presented as though it does. Access may be limited if usage threatens site availability.